BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27714265)

  • 1. Synthesis of HIV-1 capsid protein assembly inhibitor (CAP-1) and its analogues based on a biomass approach.
    Romashov LV; Ananikov VP
    Org Biomol Chem; 2016 Dec; 14(45):10593-10598. PubMed ID: 27714265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly.
    Fader LD; Bethell R; Bonneau P; Bös M; Bousquet Y; Cordingley MG; Coulombe R; Deroy P; Faucher AM; Gagnon A; Goudreau N; Grand-Maître C; Guse I; Hucke O; Kawai SH; Lacoste JE; Landry S; Lemke CT; Malenfant E; Mason S; Morin S; O'Meara J; Simoneau B; Titolo S; Yoakim C
    Bioorg Med Chem Lett; 2011 Jan; 21(1):398-404. PubMed ID: 21087861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: structure-activity relationships (SAR) of the C3-phenyl moiety.
    Fader LD; Landry S; Goulet S; Morin S; Kawai SH; Bousquet Y; Dion I; Hucke O; Goudreau N; Lemke CT; Rancourt J; Bonneau P; Titolo S; Amad M; Garneau M; Duan J; Mason S; Simoneau B
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3401-5. PubMed ID: 23601710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors.
    Sun L; Zhang X; Xu S; Huang T; Song S; Cherukupalli S; Zhan P; Liu X
    Eur J Med Chem; 2021 May; 217():113380. PubMed ID: 33751981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: addressing configurational instability through scaffold modification.
    Fader LD; Landry S; Morin S; Kawai SH; Bousquet Y; Hucke O; Goudreau N; Lemke CT; Bonneau P; Titolo S; Mason S; Simoneau B
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3396-400. PubMed ID: 23583513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships (SAR) research of thiourea derivatives as dual inhibitors targeting both HIV-1 capsid and human cyclophilin A.
    Chen K; Tan Z; He M; Li J; Tang S; Hewlett I; Yu F; Jin Y; Yang M
    Chem Biol Drug Des; 2010 Jul; 76(1):25-33. PubMed ID: 20456372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography.
    Goudreau N; Lemke CT; Faucher AM; Grand-Maître C; Goulet S; Lacoste JE; Rancourt J; Malenfant E; Mercier JF; Titolo S; Mason SW
    ACS Chem Biol; 2013 May; 8(5):1074-82. PubMed ID: 23496828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsid proteins of enveloped viruses as antiviral drug targets.
    Klumpp K; Crépin T
    Curr Opin Virol; 2014 Apr; 5():63-71. PubMed ID: 24607800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HIV-1 capsid protein as a drug target: recent advances and future prospects.
    Domenech R; Neira JL
    Curr Protein Pept Sci; 2013 Dec; 14(8):658-68. PubMed ID: 24106962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein.
    Kelly BN; Kyere S; Kinde I; Tang C; Howard BR; Robinson H; Sundquist WI; Summers MF; Hill CP
    J Mol Biol; 2007 Oct; 373(2):355-66. PubMed ID: 17826792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.
    Thenin-Houssier S; de Vera IM; Pedro-Rosa L; Brady A; Richard A; Konnick B; Opp S; Buffone C; Fuhrmann J; Kota S; Billack B; Pietka-Ottlik M; Tellinghuisen T; Choe H; Spicer T; Scampavia L; Diaz-Griffero F; Kojetin DJ; Valente ST
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2195-208. PubMed ID: 26810656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer.
    Xu JP; Branson JD; Lawrence R; Cocklin S
    Bioorg Med Chem Lett; 2016 Feb; 26(3):824-828. PubMed ID: 26747394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of 2-pyridinylpyrimidines as inhibitors of HIV-1 structural protein assembly.
    Kožíšek M; Štěpánek O; Parkan K; Berenguer Albiñana C; Pávová M; Weber J; Krӓusslich HG; Konvalinka J; Machara A
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3487-90. PubMed ID: 27353536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into HIV-1 capsid inhibitors in preclinical and early clinical development as antiretroviral agents.
    Cevik M; Orkin C
    Expert Opin Investig Drugs; 2019 Dec; 28(12):1021-1024. PubMed ID: 31738620
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and antiviral activities of novel acylhydrazone derivatives targeting HIV-1 capsid protein.
    Tian B; He M; Tang S; Hewlett I; Tan Z; Li J; Jin Y; Yang M
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2162-7. PubMed ID: 19297155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicinal chemistry strategies of targeting HIV-1 capsid protein for antiviral treatment.
    Xu S; Sun L; Huang B; Liu X; Zhan P
    Future Med Chem; 2020 Jul; 12(14):1281-1284. PubMed ID: 32483985
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemical profiling of HIV-1 capsid-targeting antiviral PF74.
    Wang L; Casey MC; Vernekar SKV; Do HT; Sahani RL; Kirby KA; Du H; Hachiya A; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Eur J Med Chem; 2020 Aug; 200():112427. PubMed ID: 32438252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors.
    Zhang X; Sun L; Meuser ME; Zalloum WA; Xu S; Huang T; Cherukupalli S; Jiang X; Ding X; Tao Y; Kang D; De Clercq E; Pannecouque C; Dick A; Cocklin S; Liu X; Zhan P
    Eur J Med Chem; 2021 Dec; 226():113848. PubMed ID: 34592608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitors.
    Li J; Jiang X; Dick A; Prakash Sharma P; Chen CH; Rathi B; Kang D; Wang Z; Ji X; Lee KH; Cocklin S; Liu X; Zhan P
    Bioorg Med Chem; 2021 Oct; 48():116414. PubMed ID: 34562701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infection.
    Liu S; Lu H; Neurath AR; Jiang S
    Antimicrob Agents Chemother; 2005 May; 49(5):1830-6. PubMed ID: 15855503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.